WallStreetZenWallStreetZen

NASDAQ: CRIS
Curis Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CRIS

Based on 2 analysts offering 12 month price targets for Curis Inc.
Min Forecast
$26.00+78.57%
Avg Forecast
$26.00+78.57%
Max Forecast
$26.00+78.57%

Should I buy or sell CRIS stock?

Based on 2 analysts offering ratings for Curis Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CRIS stock forecasts and price targets.

CRIS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-09
lockedlocked$00.00+00.00%2023-11-17

1 of 1

Forecast return on equity

Is CRIS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
36.1%

Forecast return on assets

Is CRIS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CRIS revenue forecast

What is CRIS's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$10.1M+0.92%
Avg 2 year Forecast
$10.2M+1.97%
Avg 3 year Forecast
$10.0M-0.03%
CRIS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CRIS revenue growth forecast

How is CRIS forecast to perform vs Biotechnology companies and vs the US market?
Company
0.28%
Industry
38.51%
Market
10.3%
CRIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CRIS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CRIS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRIS$14.56$26.00+78.57%Strong Buy
ALVR$0.75$1.17+56.43%Hold
QTTB$26.45$47.50+79.58%Strong Buy
PMVP$1.64$5.67+246.61%Strong Buy
BTAI$2.75$7.25+163.64%Strong Buy
View Top Biotech Stocks

Curis Stock Forecast FAQ

Is Curis Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CRIS) stock is to Strong Buy CRIS stock.

Out of 2 analysts, 1 (50%) are recommending CRIS as a Strong Buy, 1 (50%) are recommending CRIS as a Buy, 0 (0%) are recommending CRIS as a Hold, 0 (0%) are recommending CRIS as a Sell, and 0 (0%) are recommending CRIS as a Strong Sell.

If you're new to stock investing, here's how to buy Curis stock.

What is CRIS's revenue growth forecast for 2024-2026?

(NASDAQ: CRIS) Curis's forecast annual revenue growth rate of 0.28% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.3%.

Curis's revenue in 2024 is $10,023,000.On average, 2 Wall Street analysts forecast CRIS's revenue for 2024 to be $59,618,670, with the lowest CRIS revenue forecast at $59,058,732, and the highest CRIS revenue forecast at $60,178,608. On average, 2 Wall Street analysts forecast CRIS's revenue for 2025 to be $60,237,549, with the lowest CRIS revenue forecast at $59,058,732, and the highest CRIS revenue forecast at $61,416,366.

In 2026, CRIS is forecast to generate $59,058,732 in revenue, with the lowest revenue forecast at $59,058,732 and the highest revenue forecast at $59,058,732.

What is CRIS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CRIS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CRIS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CRIS price target, the average CRIS price target is $26.00, with the highest CRIS stock price forecast at $26.00 and the lowest CRIS stock price forecast at $26.00.

On average, Wall Street analysts predict that Curis's share price could reach $26.00 by Feb 9, 2025. The average Curis stock price prediction forecasts a potential upside of 78.57% from the current CRIS share price of $14.56.

What is CRIS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CRIS) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.